4 years ago

T Cell Subsets Predicting Belatacept-Resistant Rejection: Finding the Root Where the Trouble Starts

T. Wekerle
A nonhuman primate study from Mathews et al (page 2285) and a clinical study from Cortes-Cerisuelo et al (page 2350) identify pretransplant T cell subsets predicting the risk of rejection with belatacept therapy, defining biomarkers that may eventually allow personalization of immunosuppression based on pretransplant immune status and thus lead to increased biomarker-driven belatacept use.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1111/ajt.14390

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.